Literature DB >> 15061990

[The relationship between gap junctional remodeling and atrial fibrillation in patients with rheumatic heart disease].

Da-qiang Li1, Yi-bai Feng, Hui-qin Zhang.   

Abstract

OBJECTIVE: To investigate the relationship between the alternations in the expression and distribution of connexin 40 (Cx40) and connexin 43 (Cx43) and atrial fibrillation (AF) in patients with rheumatic heart disease.
METHODS: Biopsy was conducted to take specimens of right atrial appendage (RAA) from 32 patients with rheumatic heart disease, 21 with AF and 11 with sinus rhythm (SR) during valve replacement. The protein levels of Cx40 and Cx43 were examined by immunoconfocal microscopy and Western blotting. The former was also used to observe the distribution of Cx40 and Cx43 double-labeled with antibodies against Cx40 and Cx43.
RESULTS: Immunoconfocal microscopy showed that the relative expression level of Cx40 protein in the specimens of RAA in the chronic AF group was (0.67 microm(2)/ microm(3) +/- 0.09 microm(2)/ microm(3)), significantly lower than that in the SR group (1.45 microm(2)/ microm(3) +/- 0.16 microm(2)/ microm(3)) (P < 0.01). There was no significant difference in the expression of Cx43 protein between the two groups. Distributed inhomogeneously, Cx40 and Cx43 were mainly located at the side to side interconnections, instead of being confined to the intercalated discs, as observed in the patients with SR. The results of Western blotting were similar to those of immunoconfocal microscopy.
CONCLUSION: The reduction and redistribution of Cx40 and Cx43 contribute to initiation and persistence of AF in patients with rheumatic heart disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061990

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

Review 1.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

2.  Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation.

Authors:  S Dhein; S Rothe; A Busch; D M Rojas Gomez; A Boldt; A Reutemann; T Seidel; A Salameh; B Pfannmüller; A Rastan; M Kostelka; F W Mohr
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats.

Authors:  S Dhein; N Duerrschmidt; A Scholl; A Boldt; J S Schulte; B Pfannmüller; D Rojas-Gomez; A Scheffler; J-A Haefliger; N Doll; F-W Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-16       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.